Disclosure of Relationships

It is the policy of Baylor College of Medicine that the provider and contributors disclose the existence of any significant financial or other relationship with the grantor or companies whose products or services may be discussed in the activity, e.g., research grant support, consultancies, etc.

The contributor listed below has disclosed a financial interest or other relationship with a commercial concern related directly or indirectly to this educational activity (names of companies are listed after each contributor's name). Baylor College of Medicine does not view the existence of these interests or relationships as implying bias or decreasing the value of the presentation.

The following contributor has reported no financial interest or other relationships with companies whose products or services are discussed in this activity: Amy B. Middleman, MD, MPH, MSEd.

Food and Drug Administration Disclosure

Some drugs and medical devices may have United States Food and Drug Administration (FDA) clearance for specific intended use only or for use in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device that he or she uses in clinical practice and to use these products in compliance with applicable law.

Baylor College of Medicine requires that all contributors identify and disclose any “off-label” uses of pharmaceutical and medical device products. Physicians are urged to fully review all the available data on new products or procedures before using them to treat patients.

The following contributor in this activity has reported no discussion of “off-label” uses of pharmaceutical or medical device products in her presentation: Amy B. Middleman, MD, MPH, MSEd.

This online enduring material was produced by Baylor College of Medicine, Office of Continuing Medical Education, with the assistance of the Center for Collaborative and Interactive Technologies, Baylor College of Medicine, Houston.